Tricuspid valve endocarditis in the era of the opioid epidemic.
Publication/Presentation Date
5-1-2018
Abstract
BACKGROUND AND AIM: We reviewed our institutional experience with tricuspid valve endocarditis to understand the impact of the opioid epidemic on the incidence of right heart endocarditis.
METHODS: We retrospectively reviewed all cases of tricuspid endocarditis managed surgically from January of 2011 to May of 2017. There were no exclusion criteria.
RESULTS: A total of 126 patients were identified. There were seven cases in 2011 and 36 in 2016. The average age of the patients decreased from 52.85 ± 19.6 years in 2011 to 39.2 ± 12.9 in 2017. Caucasians comprised 71% of the patients in 2011 and 75% in 2016. Tricuspid valve replacement was performed in 74 patients (58.73%) and repair was performed in 52 (41.27%). Thirty-day mortality was 11.11%. Reoperation, stroke and renal failure requiring dialysis during the index hospitalization were 5.6%, 0.8%, and 8%, respectively. Staphylococcus aureus, found in 43% of cases, was the most common isolate throughout the study period. Streptococcus was the second most common causative agent.
CONCLUSIONS: In a span of 5 years, our institution has noted a fivefold increase in surgical volume for tricuspid endocarditis, most likely related to the impact of the opioid epidemic.
Volume
33
Issue
5
First Page
260
Last Page
264
ISSN
1540-8191
Published In/Presented At
Wallen, T. J., Szeto, W., Williams, M., Atluri, P., Arnaoutakis, G., Fults, M., Sultan, I., Desai, N., Acker, M., & Vallabhajosyula, P. (2018). Tricuspid valve endocarditis in the era of the opioid epidemic. Journal of cardiac surgery, 33(5), 260–264. https://doi.org/10.1111/jocs.13600
Disciplines
Medicine and Health Sciences
PubMedID
29663522
Department(s)
Department of Surgery
Document Type
Article